Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study.
作者信息
Lasheras-Pérez Miguel A, Palacios-Diaz Rodolfo D, González-Delgado Víctor A, Cobreros Lorena V, Pereira-Resquin Galván Gabriel O, Miquel-Miquel Javier, Labrandero Hoyos Carolina, Zaragoza Ninet Violeta, Melgosa Ramos Francisco J, Sánchez-Motilla José M, Navarro-Blanco Fernando, Martín-Torregrosa Daniel, Botella-Estrada Rafael, Rodríguez-Serna Mercedes
机构信息
Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain.
Department of Dermatology, Valencia University Clinical Hospital, Valencia, Spain.
出版信息
Int J Dermatol. 2024 Mar;63(3):402-404. doi: 10.1111/ijd.17030. Epub 2024 Jan 16.
PMID:38229523
Abstract
摘要
相似文献
1
Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study.
Int J Dermatol. 2024 Mar;63(3):402-404. doi: 10.1111/ijd.17030. Epub 2024 Jan 16.
2
Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: A safe and effective practice?
J Eur Acad Dermatol Venereol. 2023 May;37(5):e691-e692. doi: 10.1111/jdv.18908. Epub 2023 Feb 6.
3
Successful dose reduction of dupilumab in atopic dermatitis.
Br J Dermatol. 2023 Apr 20;188(5):678-679. doi: 10.1093/bjd/ljad011.
4
Evaluation of dupilumab dosing regimen in patients with persistently controlled atopic dermatitis.
J Eur Acad Dermatol Venereol. 2023 Dec;37(12):e1426-e1429. doi: 10.1111/jdv.19348. Epub 2023 Jul 21.
5
Dupilumab alleviates pruritus regardless of skin improvement in adults with atopic dermatitis: A cohort study.
J Am Acad Dermatol. 2024 Jan;90(1):195-196. doi: 10.1016/j.jaad.2023.09.043. Epub 2023 Sep 24.
6
Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis.
JAMA Dermatol. 2024 Mar 1;160(3):370. doi: 10.1001/jamadermatol.2023.6198.
7
Emerging Role of Atopic Dermatitis Control Tool in Long-Term Monitoring of Patients With Moderate-to-Severe Atopic Dermatitis Treated With Dupilumab.
Dermatitis. 2024 Jan-Feb;35(S1):S107-S108. doi: 10.1089/derm.2023.0052. Epub 2023 Aug 18.
8
Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: A US nationwide cohort study.
J Am Acad Dermatol. 2024 Jan;90(1):134-137. doi: 10.1016/j.jaad.2023.08.025. Epub 2023 Aug 19.
9
Benefits of treatment with dupilumab for children aged 6-11 years with severe atopic dermatitis.
Br J Dermatol. 2023 Jul 17;189(2):e39. doi: 10.1093/bjd/ljad201.
10
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis.
Allergy. 2022 Nov;77(11):3398-3407. doi: 10.1111/all.15439. Epub 2022 Jul 29.
引用本文的文献
1
Strategies for Tapering the Dosage of Biologics Targeting Type 2 Inflammation: A Systematic Review.
Curr Allergy Asthma Rep. 2025 Jul 28;25(1):32. doi: 10.1007/s11882-025-01214-9.
Zotero 插件